|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
Á¦ ¸ñ |
TnvzMuSQijMMxfSYwQS |
|
ÀÌ ¸§ |
Damien |
³¯ Â¥ |
2018/06/29 |
Á¶ ȸ |
8 |
|
I don't like pubs www.cashandgold.ca
The Bethesda, Maryland-based National Cancer Institute (NCI) and academic researchers it sponsors have just launched "super responder" initiatives to match patients having little-known gene mutations to drugs already shown to help others with the same mutations, even if their tumors are for a variety of organs.
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|